Tyler-Stone Wealth Management’s Roivant Sciences ROIV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-250
Closed -$2.64K 798
2024
Q2
$2.64K Hold
250
﹤0.01% 828
2024
Q1
$2.63K Hold
250
﹤0.01% 822
2023
Q4
$2.81K Hold
250
﹤0.01% 780
2023
Q3
$3K Hold
250
﹤0.01% 785
2023
Q2
$3K Buy
+250
New +$2.24K ﹤0.01% 778
2022
Q4
$2K Hold
250
﹤0.01% 766
2022
Q3
$1K Hold
250
﹤0.01% 826
2022
Q2
$1K Buy
+250
New +$992 ﹤0.01% 829
2022
Q1
Sell
-250
Closed -$3K 929
2021
Q4
$3K Buy
+250
New +$2.08K ﹤0.01% 769

Other funds holding ROIV

Tyler-Stone Wealth Management's ROIV Position: Q3 2024 in Review

Tyler-Stone Wealth Management sold out of Roivant Sciences (ROIV) in Q3 2024, closing a stake of 250 shares — an estimated $2.64K sold.

Tyler-Stone Wealth Management first reported a position in ROIV in Q4 2021 and held it in 9 quarters. The position peaked at $3K in Q3 2023. 293 funds tracked by Wall St. Rank hold ROIV as of Q3 2024.

  • Tyler-Stone Wealth Management reported no remaining Roivant Sciences position as of Q3 2024 after selling out during the quarter.
  • Tyler-Stone Wealth Management sold 250 Roivant Sciences shares in Q3 2024, an estimated $2.64K.
  • Tyler-Stone Wealth Management first reported a position in Roivant Sciences in Q4 2021 and held it in 9 quarters.
  • Tyler-Stone Wealth Management's Roivant Sciences position peaked at $3K in Q3 2023.
  • 293 funds tracked by Wall St. Rank held Roivant Sciences as of Q3 2024.

Based on Tyler-Stone Wealth Management's 13F filing for Q3 2024, filed 4 Nov 2024.